Swooping for biotech
Article Abstract:
Pharmaceutical companies have long bought biotech companies as a means of expanding their drug pipelines but several factors have converged to accelerate the process. Analysts claim that public offerings for biotechnology companies have generated disappointing returns, making companies more willing to be bought out and stagnant biotechnology share prices make acquisitions relatively cheap.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Meeting in the middle
Article Abstract:
The U.S. Congress is trying to devise new methods to create a pathway to produce lower-cost copies of various biotech drugs without eliminating the incentives to create the breakthrough medicines.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
No longer the upstart
Article Abstract:
The Biotechnology Industry Organization (BIO) has grown from notable to a high-impact trade organization. However, the vital thing is to get people to understand the potential of BIO.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Chemistry for everyone. Tethering on the edge. Ilya Prigogine (1917-2003)
- Abstracts: Iron seeding creates fleeting carbon sink in Southern Ocean. The philosopher of photons
- Abstracts: Doping control for nanotubes. Doping semiconductor nanocrystals. Surface transfer doping of diamond
- Abstracts: Pushing for power. Network of concern
- Abstracts: Single-exciton optical gain in semiconductor nanocrystals. Hear the noise. Energy-transfer pumping of semiconductor nanocrystals using an epitaxial quantum well